Accutane (Isotretinoin) Pregnancy & Lactation Safety

HealthRX.com

Isotretinoin must not be taken during pregnancy

Print or save as PDF

Key numbers

  • 8 daysBreastfeeding not recommended during treatment and for at least this long after the last doseSource: dailymed.nlm.nih.gov, as cited Nov 7, 2026
  • 7 daysPrescription must be obtained within this many days of the pregnancy test for patients who can get pregnantSource: dailymed.nlm.nih.gov, as cited Nov 7, 2026
  • 30-day supplyMaximum amount pharmacies dispense per iPLEDGE prescription, with no refills allowedSource: dailymed.nlm.nih.gov, as cited Nov 7, 2026
  • 1 monthPatients must not donate blood during treatment and for this long after stopping isotretinoinSource: dailymed.nlm.nih.gov, as cited Nov 7, 2026

From the public record

Registered clinical studies of isotretinoin in pregnancy

ClinicalTrials.gov lists 11 registered studies that name isotretinoin as an intervention and list pregnancy as a condition, as of 2026-11-11. Of these, 1 are recruiting, 7 are completed and 2 are phase 3 studies.

Registered clinical studies of isotretinoin in pregnancy: the figures
MeasureValue
Registered studies11
Recruiting now1
Not yet recruiting0
Completed7
Terminated, withdrawn or suspended2
Phase 3 (including phase 2/3)2
Phase 2 (including phase 1/2)9
Phase 10

Source: NIH National Library of Medicine, ClinicalTrials.gov, data as of Nov 11, 2026

How this was calculated

Searched ClinicalTrials.gov for studies naming the drug as an intervention with the stated filter, downloaded every matching record and counted by status and phase. Combined phases are counted under the higher phase.

Scope: Studies whose intervention field matches isotretinoin and that list pregnancy as a condition, all statuses

A registered study is not a result. Counts include studies where the drug is a comparator or background treatment, and studies that never finished or reported. The filter relies on how each study was registered.

Download the data (CSV)

At a glance

  • Pregnancy / Contraindicated; boxed warning for embryo-fetal toxicity [1]
  • Accutane label pregnancy category / Category X [2]
  • Access / FDA-approved capsules only, through the iPLEDGE REMS [1]
  • Testing before a first prescription / Screening test, then a confirmatory test, both in a medical setting, at least 30 days apart [1]
  • Each prescription / Negative test within the previous 7 days; maximum 30-day supply, no refills [1]
  • Breastfeeding / Not recommended during treatment and for at least 8 days after the last dose [1]
  • Blood donation / Not during treatment or for 1 month afterward [1]

Is isotretinoin safe to take during pregnancy?

No. Isotretinoin is contraindicated in pregnancy, and the Absorica/Absorica LD label opens with a boxed warning headed EMBRYO-FETAL TOXICITY - CONTRAINDICATED IN PREGNANCY [1]. The label says there is an extremely high risk that life-threatening birth defects will result if pregnancy occurs while taking any amount of the drug, even for short periods, and that potentially any fetus exposed during pregnancy can be affected [1]. The older Accutane label lists Pregnancy: Category X [2].

The label also states that there are no accurate means of determining prenatally whether an exposed fetus has been affected [1].

Questions worth asking

Choose the questions you want to keep

What harm has been documented?

Isotretinoin exposure during pregnancy has been followed by major congenital malformations, spontaneous abortion and premature birth [1]. The malformations documented in the label involve the face, eyes, ears, skull, central nervous system, cardiovascular system, and thymus and parathyroid glands [1].

External abnormalities listed include skull abnormality; ear abnormalities including anotia, micropinna and small or absent external auditory canals; eye abnormalities including microphthalmia; facial dysmorphia; and cleft palate [1]. Internal abnormalities listed include cerebral and cerebellar malformations, hydrocephalus, microcephaly, cranial nerve deficit, cardiovascular abnormalities, thymus gland abnormality and parathyroid hormone deficiency [1]. Death has occurred in some cases as a result of these malformations, and cases of IQ scores below 85, with or without other abnormalities, have been reported in children exposed in utero [1].

Isotretinoin is closely related to vitamin A, and the label says to avoid supplements containing vitamin A during treatment [1].

What does iPLEDGE require before and during treatment?

Isotretinoin is available only through a restricted program, the iPLEDGE REMS, because of the risk of embryo-fetal toxicity [1]. Prescribers must be certified, pharmacies must be certified, wholesalers must be registered, and every patient must be enrolled [1].

For a patient who can get pregnant, the Absorica label describes this sequence [1]:

  • A screening pregnancy test in a medical setting.
  • A confirmatory test in a medical setting at least 30 days after the screening test, and after at least 30 days of using the chosen pregnancy prevention method (two forms of contraception or committed abstinence).
  • During treatment, a pregnancy test within 7 days before each prescription, done in a medical setting or by home pregnancy test if the prescriber instructs.
  • Pregnancy testing also after treatment.

The prescription must be obtained within 7 days of the pregnancy test collection, and the patient must show comprehension of the risk and REMS requirements before each prescription is dispensed [1]. Pharmacies dispense a maximum 30-day supply with a Medication Guide and no refills [1].

Isotretinoin is available only as FDA-approved capsules through iPLEDGE. Compounded drugs are not FDA-approved, and FDA does not verify their safety, effectiveness or quality before marketing, so a compounded isotretinoin product would sit outside this system [3][1].

What changed in 2026?

FDA approved modifications to the iPLEDGE REMS on 9 February 2026 [4][5]. With prescriber permission, patients may complete pregnancy tests outside a medical setting, such as at home, during and after treatment; pre-treatment tests must still be done in a medical setting [4][5]. A patient who does not pick up a prescription inside the 7-day window can repeat the test immediately, without an added waiting period [4]. Monthly documentation of counseling is no longer required for patients who cannot get pregnant, and the 30-day prescription window no longer applies to them [4].

FDA's page, current as of 16 June 2026, gives 15 November 2026 as the planned implementation date, moved from the earlier 8 August 2026 date, to allow time to test system updates [4]. Until the changes are fully implemented, FDA says it will continue to exercise enforcement discretion on pregnancy testing requirements [4].

What birth control does the label require?

The Accutane label says it is critically important for patients who can become pregnant to select and commit to two forms of effective contraception used simultaneously, at least one of which must be a primary form [2]. Micro-dosed progesterone preparations - minipills that do not contain an estrogen - are described as an inadequate form of contraception during treatment [1][2]. Contraception is not required if the patient commits to continuous abstinence from sexual contact that could result in pregnancy, has had a hysterectomy or bilateral oophorectomy, or is medically confirmed to be postmenopausal [1].

Isotretinoin did not cause clinically significant changes in the pharmacokinetics of norethindrone and ethinyl estradiol when the two were given together as an oral contraceptive [1]. The label says it is not known whether isotretinoin interacts with other oral contraceptives [1]. It also notes that any birth control method can fail, and that pregnancies have been reported in patients using combined oral contraceptives [2].

What if pregnancy happens during treatment?

The label says that if pregnancy occurs during treatment, the drug is to be discontinued immediately and the patient referred to an obstetrician-gynecologist experienced in reproductive toxicity for further evaluation and counseling [1]. It also says any suspected fetal exposure during treatment or within 1 month after it is to be reported immediately to FDA MedWatch at 1-800-FDA-1088 and to the iPLEDGE pregnancy registry at 1-866-495-0654 or ipledgeprogram.com [1]. The iPLEDGE REMS includes a pregnancy registry for patients who become pregnant during treatment [5].

What people on Reddit report

Accounts from people who became pregnant or worried about pregnancy while taking isotretinoin, plus comments on how testing and contraception rules differ by country.

Annabelle_Sugarsweet · pregnant

I had to sign a document when I was on it that I would get a termination if I got pregnant and also had to be on LARC so the implant to even get given it.

A former patient recalls signing a form and needing a long-acting contraceptive before getting the drug.

Read the source discussion

caityjay25 · pregnant

I am so sorry you're going through this. MD here. Unfortunately accurate causes devastating birth defects very early in pregnancy - not in every pregnancy every time, but there is a high rate of defects.

A doctor commenter says birth defects are common early in pregnancy and advises an early OBGYN visit.

Read the source discussion

sneekysox531 · pregnant

I just finished 8 months of Accutane not even 2 months ago and my dermatologist has told me to not get pregnant a year POST-accutane, so the risks of complications are incredibly high especially considering you were in the midst of taking it.

A former patient says a dermatologist advised avoiding pregnancy for a year after finishing treatment.

Read the source discussion

harle-quin · pregnant

I worked in pharmacy, and it is one of the most strict medications to dispense. The doctor, patient, and pharmacy all have to be on the same page, at the same time.

A former pharmacy worker says the dispensing process requires the prescriber, patient and pharmacy to be in step.

Read the source discussion

exhilaro · pregnant

A lot of the replies here are very US centric. In many other countries there is no requirement for ongoing pregnancy testing outside of the initial test, more than one type of BC, massive labels on the box etc.

A commenter says testing and contraception rules differ by country and that some replies are US-centric.

Read the source discussion

Can you breastfeed while taking isotretinoin?

No. The Absorica label states that there are no data on the presence of isotretinoin in human or animal milk, on the effects on the breastfed infant, or on the effects on milk production, and that because of the potential for serious adverse reactions in nursing infants, breastfeeding is not recommended during treatment and for at least 8 days after the last dose [1].

What about patients who cannot get pregnant?

Every patient is enrolled in iPLEDGE, including patients who cannot get pregnant [1]. Their REMS duties are not to share isotretinoin and not to donate blood [1]. The label says patients must not donate blood during treatment and for 1 month after discontinuation, because the blood might be given to a pregnant patient whose fetus must not be exposed to isotretinoin [1]. These patients are counseled on the risk and REMS requirements at enrollment [4].

Check what you know

Think you have it? Try 4 quick questions and see what the article says.

1. According to the Absorica label, how long after the last dose should breastfeeding be avoided?

Question 1 of 4

Score: 0 right, 0 of 4 answered

Frequently asked questions

Is isotretinoin safe during pregnancy?
No. Isotretinoin is contraindicated in pregnancy, and its boxed warning says there is an extremely high risk of life-threatening birth defects if pregnancy occurs while taking any amount, even for short periods [1].
How many pregnancy tests does iPLEDGE require before a first prescription?
Two, both in a medical setting: a screening test, then a confirmatory test at least 30 days later and after at least 30 days of the chosen pregnancy prevention method. After that, a test is required within 7 days before each prescription [1].
How long after the last dose can you breastfeed?
The Absorica label says breastfeeding is not recommended during treatment and for at least 8 days after the last dose [1].
Does isotretinoin make birth control pills less effective?
Isotretinoin did not cause clinically significant pharmacokinetic changes in norethindrone and ethinyl estradiol given as an oral contraceptive. Whether it interacts with other oral contraceptives is not known, and minipills without estrogen are described as inadequate during treatment [1].
Can you donate blood while taking isotretinoin?
No. The label says patients must not donate blood during treatment or for 1 month after stopping, because the blood might be given to a pregnant patient whose fetus must not be exposed [1].
What happens if pregnancy occurs during isotretinoin treatment?
The label says to discontinue isotretinoin immediately and refer the patient to an obstetrician-gynecologist experienced in reproductive toxicity. It says suspected fetal exposure is to be reported immediately to FDA MedWatch at 1-800-FDA-1088 and the iPLEDGE pregnancy registry at 1-866-495-0654 [1].

Reader questions

What people actually ask

Short answers drawn from the sources this article cites.

Can I go on Accutane while breastfeeding?

No. Breastfeeding is not recommended during treatment and for at least 8 days after the last dose. The Absorica label says there are no data on whether isotretinoin passes into human or animal milk, or on its effects on a breastfed infant, and that serious adverse reactions in nursing infants are possible.

Has anyone had a baby while on Accutane?

Pregnancies during isotretinoin exposure have been followed by major congenital malformations, spontaneous abortion and premature birth. Death has occurred in some cases from these malformations, and IQ scores below 85 have been reported in children exposed in utero.

References

Show all 7 referencesHide references
  1. U.S. National Library of Medicine, DailyMed. Absorica and Absorica LD isotretinoin capsules (Sun Pharma) prescribing information. Absorica and Absorica LD isotretinoin capsules (Sun Pharma) label
  2. U.S. National Library of Medicine, DailyMed. Accutane-format isotretinoin label (older non-PLR format) prescribing information. Accutane-format isotretinoin label (older non-PLR format) label
  3. Compounding and the FDA: Questions and Answers | FDA.
  4. iPLEDGE Risk Evaluation and Mitigation Strategy (REMS) | FDA.
  5. Questions and Answers on the iPLEDGE REMS | FDA.
  6. Reddit participants. Pregnant while on Accutane (r/pregnant). Accessed 2026-11-11.
  7. Reddit participants. Isotretinoin pregnancy (r/pregnant). Accessed 2026-11-11.
Evidence overview for Accutane (Isotretinoin) Pregnancy & Lactation Safety